Endometriosis: basic research

In: Human Reproduction · 2008 · vol. 23(Supplement 1) , pp. i188–i191 · doi:10.1093/humrep/den1099 · W4255355831
OA: bronze CC0
📄 Open PDF View on OpenAlex View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-23 ⓘ

This review examines anti-Müllerian hormone as a marker for oocyte yield and treatment outcomes in IVF, noting that its levels remain unaffected by gonadal hormones throughout the menstrual cycle.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

unaffected by gonadal hormones, so blood samples may be collected at any time during the menstrual cycle. AMH has been shown to be associated with oocyte yield in IVF, and some studies suggest that AMH is related to treatment outcome (for review see, Broekmans, Hum Reprod Update, 2007).

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK